3034:HK:HK-CSOP Metaverse Concept ETF (HKD)

ETF | Others |

Last Closing

USD 9.025

Change

-0.11 (-1.15)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

N/A

USD 146.84B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

+0.16 (+0.23%)

USD 24.81B
2823:HK iShares FTSE A50 China

-0.16 (-1.14%)

USD 21.23B
2801:HK iShares Core MSCI China ETF

-0.12 (-0.59%)

USD 20.56B
83188:HK ChinaAMC CSI 300 Index ETF

-0.48 (-1.16%)

USD 13.48B
82822:HK CSOP FTSE China A50

-0.24 (-1.94%)

USD 9.69B
9067:HK iShares Hang Seng TECH ETF

N/A

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

+0.03 (+0.33%)

USD 9.22B
9010:HK iShares Core MSCI AC Asia ex J..

N/A

USD 3.03B

ETFs Containing 3034:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.25% 77% C+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.25% 75% C 75% C
Trailing 12 Months  
Capital Gain 29.48% 82% B 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.48% 81% B- 80% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.66% 79% B- 67% D+
Dividend Return 4.66% 77% C+ 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.02% 73% C 91% A-
Risk Adjusted Return 38.72% 81% B- 82% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike